Human ST6 GalNAc alpha-2,6-sialyltransferase V/ST6GALNA Antibody

R&D Systems, part of Bio-Techne | Catalog # MAB6715

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
MAB6715
MAB6715-SP
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG2A Clone # 719526

View all ST6 GalNAc alpha-2,6-sialyltransferaseV/ST6GALNAC5 Antibodies »

Product Specifications

Immunogen

Chinese hamster ovary cell line CHO-derived recombinant human GalNAc alpha-2,6-sialyltransferase V/ST6GALNAC5
Gly30-Phe336
Accession # Q9BVH7

Specificity

Detects human GalNAc alpha-2,6-sialyltransferase V/ST6GALNAC5 in direct ELISAs. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) ST6GALNAC4 or rhST6GALNAC6 is observed.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2A

Scientific Data Images for Human ST6 GalNAc alpha-2,6-sialyltransferase V/ST6GALNA Antibody

Detection of Human GalNAc a-2,6 sialyltransferase V/ ST6GALNAC5 antibody by Western Blot.

Detection of Human GalNAc alpha‑2,6 sialyltransferase V/ ST6GALNAC5 by Western Blot.

Western blot shows lysates of MDA-MB-231 human breast cancer cell line. PVDF membrane was probed with 2 µg/mL of Mouse Anti-Human GalNAc a-2,6-sialyltransferase V/ST6GALNAC5 Monoclonal Antibody (Catalog # MAB6715) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF007). A specific band was detected for GalNAc a-2,6-sialyltransferase V/ST6GALNAC5 at approximately 36 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

Applications for Human ST6 GalNAc alpha-2,6-sialyltransferase V/ST6GALNA Antibody

Application
Recommended Usage

Western Blot

2 µg/mL
Sample: MDA‑MB‑231 human breast cancer cell line

Formulation, Preparation, and Storage

Purification

Protein A or G purified from hybridoma culture supernatant

Reconstitution

Sterile PBS to a final concentration of 0.5 mg/mL. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: ST6 GalNAc alpha-2,6-sialyltransferaseV/ST6GALNAC5

Gangliosides are acidic glycosphingolipids that contain one or more sialic acid residues (1). They are abundant in the nervous system, where they play crucial modulatory roles in cellular recognition, interaction, adhesion, and signal transduction, particularly during early developmental stages. The expression of gangliosides in the nervous system is developmentally regulated through various sialyltransferases (2). ST6GALNAC5 is a sialyltransferase involved in the biosynthesis of ganglioside GD1a (NeuAc alpha2,3Gal beta1,3GalNAc beta1,4(NeuAc alpha2,3)Gal beta1,4Glc beta1-Cer) from GM1b (NeuAc alpha2,3Gal beta1,3GalNAc beta1,4Gal beta1,4Glc beta1-Cer), and its expression is restricted to the brain (3, 4). ST6GALNAC5 has been identified as a key player in the metastasis of breast cancer cells to the brain by potentially enabling the cancer cells to cross the blood-brain barrier (5, 6). The recombinant ST6GALNAC5 was active on fetuin from fetal calf serum when assayed using a phosphatase-coupled method (7) suggesting the substrate specificity of ST6GALNAC5 may require further characterization.

References

  1. Kolter, T. et al. (2002) J. Biol. Chem. 277:25859.
  2. Yu, R.K. et al. (2008) Glycoscience DOI: 10.1007/978-3-540-30429-6_41.
  3. Okajima, T. et al. (1999) J. Biol. Chem.274:30557.
  4. Harduin-Lepers, A. et al. (2005) Glycobiology 15:805.
  5. Bos, P.D. et al. (2009) Nature 459:1005.
  6. Arshad, F. et al. (2011). Patholog. Res. Int. DOI: 10.4061/2011/920509.
  7. Wu, Z.L. et al. (2010) Glycobiology DOI: 10.1093/glycob/cwq187.

Long Name

ST6 alpha-N-acetylGalactosaminide alpha-2,6-sialyltransferase 5

Alternate Names

GD1 alpha synthase, SIAT7E, ST6GalNAcV

Entrez Gene IDs

81849 (Human); 26938 (Mouse)

Gene Symbol

ST6GALNAC5

UniProt

Q9BVH7

Additional ST6 GalNAc alpha-2,6-sialyltransferaseV/ST6GALNAC5 Products

Product Documents for Human ST6 GalNAc alpha-2,6-sialyltransferase V/ST6GALNA Antibody

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Human ST6 GalNAc alpha-2,6-sialyltransferase V/ST6GALNA Antibody

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.